Military Medical Academy named after SM Kirov, the Russian Ministry of Defense, Hospital Therapeutic Department and Clinic Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2016
NCT02930161
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

sodium succinate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatty Liver (Phase 2)

Liver Diseases (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1